vTv Therapeutics (VTVT)
(Delayed Data from NSDQ)
$22.38 USD
+1.03 (4.83%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $22.97 +0.59 (2.64%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
vTv Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VTVT 22.38 +1.03(4.83%)
Will VTVT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VTVT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTVT
The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics
Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More
VTVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VTVT
VTVT forms Pocket Pivot on September 19
VTVT's price rises by 1.52% on September 19, though its technical setup remains stable.
Is VTVT building bullish momentum? Slingshot Bullish shows up after sliding 0.69%
vTv Therapeutics trading resumes
vTv Therapeutics trading resumes